Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 2
2013 3
2014 1
2015 4
2016 3
2017 3
2018 2
2019 3
2021 10
2022 9
2023 13
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study.
Tsai CJ, Yang JT, Shaverdian N, Patel J, Shepherd AF, Eng J, Guttmann D, Yeh R, Gelblum DY, Namakydoust A, Preeshagul I, Modi S, Seidman A, Traina T, Drullinsky P, Flynn J, Zhang Z, Rimner A, Gillespie EF, Gomez DR, Lee NY, Berger M, Robson ME, Reis-Filho JS, Riaz N, Rudin CM, Powell SN; CURB Study Group. Tsai CJ, et al. Lancet. 2024 Jan 13;403(10422):171-182. doi: 10.1016/S0140-6736(23)01857-3. Epub 2023 Dec 14. Lancet. 2024. PMID: 38104577 Clinical Trial.
Proton Therapy in the Management of Pancreatic Cancer.
Kobeissi JM, Simone CB 2nd, Lin H, Hilal L, Hajj C. Kobeissi JM, et al. Among authors: hajj c. Cancers (Basel). 2022 Jun 4;14(11):2789. doi: 10.3390/cancers14112789. Cancers (Basel). 2022. PMID: 35681769 Free PMC article. Review.
Proton Therapy in the Management of Hepatocellular Carcinoma.
Kobeissi JM, Hilal L, Simone CB 2nd, Lin H, Crane CH, Hajj C. Kobeissi JM, et al. Among authors: hajj c. Cancers (Basel). 2022 Jun 12;14(12):2900. doi: 10.3390/cancers14122900. Cancers (Basel). 2022. PMID: 35740567 Free PMC article. Review.
Bridging Radiation Rapidly and Effectively Cytoreduces High-Risk Relapsed/Refractory Aggressive B Cell Lymphomas Prior to Chimeric Antigen Receptor T Cell Therapy.
Hubbeling H, Silverman EA, Michaud L, Tomas AA, Shouval R, Flynn J, Devlin S, Wijetunga NA, Tringale KR, Batlevi C, Dahi P, Giralt S, Lin R, Park J, Scordo M, Sauter C, Shah G, Hajj C, Salles G, Schoder H, Palomba ML, Perales MA, Yahalom J, Imber BS. Hubbeling H, et al. Among authors: hajj c. Transplant Cell Ther. 2023 Apr;29(4):259.e1-259.e10. doi: 10.1016/j.jtct.2022.12.021. Epub 2022 Dec 30. Transplant Cell Ther. 2023. PMID: 36587744 Free PMC article.
Phase 1 Dose Escalation Study of SBRT Using 3 Fractions for Locally Advanced Pancreatic Cancer.
Reyngold M, Karam SD, Hajj C, Wu AJ, Cuaron J, Lobaugh S, Yorke ED, Dickinson S, Jones B, Vinogradskiy Y, Shukla-Dave A, Do RKG, Sigel C, Zhang Z, Crane CH, Goodman KA. Reyngold M, et al. Among authors: hajj c. Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):53-63. doi: 10.1016/j.ijrobp.2023.03.036. Epub 2023 Mar 12. Int J Radiat Oncol Biol Phys. 2023. PMID: 36918130 Clinical Trial.
HCC: We Prefer Fractionation Versus Dose Reduction.
Hajj C, Crane CH. Hajj C, et al. Int J Radiat Oncol Biol Phys. 2023 Feb 1;115(2):277. doi: 10.1016/j.ijrobp.2022.08.061. Int J Radiat Oncol Biol Phys. 2023. PMID: 36621228 No abstract available.
51 results